-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, J9hy+PPmC9ddJiDCAPLwxnGRbfn3yLC9w+M43jgX2cp4g415wfqkOQ/bMaieiCcr AT3nyrt86QpK/x3Khml+CA== 0001072613-09-001172.txt : 20090805 0001072613-09-001172.hdr.sgml : 20090805 20090805093314 ACCESSION NUMBER: 0001072613-09-001172 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20090805 DATE AS OF CHANGE: 20090805 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ONCOGENEX PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000949858 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 954343413 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-45969 FILM NUMBER: 09985810 BUSINESS ADDRESS: STREET 1: 1522 217TH PLACE S.E. CITY: BOTHELL STATE: WA ZIP: 98021 BUSINESS PHONE: 4254879500 MAIL ADDRESS: STREET 1: 1522 217TH PLACE S.E. CITY: BOTHELL STATE: WA ZIP: 98021 FORMER COMPANY: FORMER CONFORMED NAME: SONUS PHARMACEUTICALS INC DATE OF NAME CHANGE: 19950825 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BDC CAPITAL INC. CENTRAL INDEX KEY: 0001430885 IRS NUMBER: 000000000 STATE OF INCORPORATION: A8 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: SUITE 300, 5 PLACE VILLE MARIE CITY: MONTREAL STATE: A8 ZIP: H3B 5E7 BUSINESS PHONE: 514-283-0869 MAIL ADDRESS: STREET 1: SUITE 300, 5 PLACE VILLE MARIE CITY: MONTREAL STATE: A8 ZIP: H3B 5E7 SC 13G/A 1 sch13g_16551.htm BDC CAPITAL INC. -- SCHEDULE 13GA (#2) Unassociated Document


 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549


SCHEDULE 13G/A

Under the Securities Exchange Act of 1934
(Amendment No. 2)*


 
Oncogenex Pharmaceuticals, Inc.
(Name of Issuer)

Common Stock, $0.001 par value
(Title of Class of Securities)

68230A 106
(CUSIP Number)

July 31, 2009
(Date of Event Which Requires Filing of this Statement)

 


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

o  Rule 13d-1(b)
x Rule 13d-1(c)

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
 
 


 
 
    CUSIP No.    68230A 106
13G
Page 2 of 6 Pages
   
1
NAMES OF REPORTING PERSONS
 
BDC Capital Inc.
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a)  o
(b)  o
 
3
SEC USE ONLY
 
 
4
CITIZENSHIP OR PLACE OF ORGANIZATION
 
Canada
 
 
 
 
5
SOLE VOTING POWER
 
269,854 shares
 
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
6
SHARED VOTING POWER
 
0 shares
 
REPORTING
PERSON
WITH
7
SOLE DISPOSITIVE POWER
 
269,854 shares
 
 
8
SHARED DISPOSITIVE POWER
 
0 shares
 
9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
269,854 shares 
10
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)   o
 
 
11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
 
4.5%
 
12
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
CO
 

    CUSIP No.    68230A 106
13G
Page 3 of 6 Pages
 

Schedule 13G

Item 1(a).
Name of Issuer: Oncogenex Pharmaceuticals, Inc.
 
 
Item 1(b).
Address of Issuer's Principal Executive Offices: 1522 217th Place S.E., Bothell, WA 98021
 
 
Item 2(a).
Name of Person Filing:  BDC Capital Inc.
 
 
Item 2(b).
Address of Principal Business Office or, if none, Residence:  Suite 300, 5 Place Ville Marie, Montreal, Quebec, Canada H3B 5E7
 
 
Item 2(c).
Citizenship: Canadian
 
 
Item 2(d).
Title of Class of Securities:  Common Stock, $0.001 par value.
 
 
Item 2(e).
CUSIP Number:  68230A 106
 
 
Item 3.
If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:

 
(a)   o
 
Broker or Dealer registered under Section 15 of the Securities Exchange Act of 1934 (the “Act”).
 
 
(b)   o
 
Bank as defined in Section 3(a)(6) of the Act.
 
 
(c)   o
 
Insurance Company as defined in Section 3(a)(19) of the Act.
 
 
(d)   o
 
Investment Company registered under Section 8 of the Investment Company Act of 1940.
 
 
(e)   o
 
An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E).
 
 
(f)   o
 
An employee benefit plan or endowment fund in accordance with  Rule 13d-1(b)(1)(ii)(F);
 
 
(g)   o
 
A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G).
 
 
(h)   o
 
A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act;
 
 
(i)    o
 
A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940;
 
 
(j)    o
 
Group, in accordance with Rule 13d-1(b)(1)(ii)(J).
 
 
Not Applicable.
 
 

    CUSIP No.    68230A 106
13G
Page 4 of 6 Pages
 

 
Item 4.
Ownership.
 
(a)      
Amount Beneficially Owned:
 
269,854 shares
 
 
(b)      
Percent of Class:
   
  4.5%
   
   
(c)      
Number of shares as to which such person has:
   
 
(i)  sole power to vote or to direct the vote:
   
 
      269,854 shares
   
  (ii)  shared power to vote or to direct the vote:
   
 
       Not applicable
   
  (iii)  sole power to dispose or direct the disposition of:
   
 
        269,854 shares
   
  (iv)  shared power to dispose or direct the disposition of:
   
 
        Not applicable
 
 
Item 5.
Ownership of Five Percent or Less of a Class.

 
If this statement is being filed to report the fact that as of the date hereof, the reporting person has ceased to be the beneficial owner of more than 5% of the class of securities, check the following:   x
 
 
Item 6.
Ownership of More than Five Percent on Behalf of Another Person.

 
Not Applicable.

 
Item 7.
Identification and Classification of the Subsidiary which Acquired the Security Being Reported on By the Parent Holding Company or Control Person.

 
Not Applicable.
 
 
Item 8.
Identification and Classification of Members of the Group.
 
 
Not Applicable.
 
 
 

    CUSIP No.    68230A 106
13G
Page 5 of 6 Pages
 


 
Item 9.
Notice of Dissolution of Group.

 
Not Applicable.
 
 
Item 10.
Certification.

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

    CUSIP No.    68230A 106
13G
Page 6 of 6 Pages
 
 
 
SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
 
 
 
 

 
Date:   August 5, 2009


By: /s/ Sylvain Gendron                         
       Sylvain Gendron
       Legal Counsel


 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
-----END PRIVACY-ENHANCED MESSAGE-----